Hypertension (journal)

From WikiMD's Medical Encyclopedia

Revision as of 00:02, 17 March 2025 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Hypertension is a peer-reviewed medical journal that publishes articles related to hypertension and cardiovascular disease. It is published monthly by the American Heart Association and its current editor-in-chief is Anna F. Dominiczak. The journal was established in 1979 and has an impact factor of 7.632, as of 2019.

Overview[edit]

Hypertension is a highly respected journal in the field of cardiovascular research. It publishes original research articles, reviews, and special reports related to hypertension and associated disorders. The journal is known for its rigorous peer-review process and high standards of scientific excellence.

History[edit]

The journal was established in 1979 by the American Heart Association. Since its inception, it has played a crucial role in disseminating important research findings in the field of hypertension and cardiovascular disease. The journal has had several distinguished editors-in-chief over the years, with the current editor being Anna F. Dominiczak.

Impact Factor[edit]

As of 2019, the journal has an impact factor of 7.632. This high impact factor reflects the journal's influence and prestige in the field of cardiovascular research.

Editorial Board[edit]

The editorial board of Hypertension consists of leading experts in the field of cardiovascular research. The board is responsible for reviewing submissions and ensuring the scientific quality of the journal's content.

See Also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.